Genovese Burford & Brothers Wealth & Retirement Plan Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-118
Closed -$13K 393
2018
Q2
$13K Hold
118
﹤0.01% 299
2018
Q1
$13K Hold
118
﹤0.01% 300
2017
Q4
$15K Buy
118
+29
+33% +$3.28K 0.04% 164
2017
Q3
$10K Hold
89
﹤0.01% 284
2017
Q2
$11K Hold
89
﹤0.01% 268
2017
Q1
$11K Hold
89
﹤0.01% 285
2016
Q4
$9K Hold
89
﹤0.01% 338
2016
Q3
$11K Hold
89
﹤0.01% 291
2016
Q2
$10K Hold
89
﹤0.01% 274
2016
Q1
$9K Hold
89
﹤0.01% 276
2015
Q4
$9K Buy
+89
New +$8.71K ﹤0.01% 265

Other funds holding ZBH

Genovese Burford & Brothers Wealth & Retirement Plan Management's ZBH Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Zimmer Biomet (ZBH) in Q3 2018, closing a stake of 118 shares — an estimated $13K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in ZBH in Q4 2015 and held it in 11 quarters. The position peaked at $15K in Q4 2017. 892 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

  • Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Zimmer Biomet position as of Q3 2018 after selling out during the quarter.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management sold 118 Zimmer Biomet shares in Q3 2018, an estimated $13K.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Zimmer Biomet in Q4 2015 and held it in 11 quarters.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management's Zimmer Biomet position peaked at $15K in Q4 2017.
  • 892 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.